Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Alberti, A.
space
  arrow  Gatta, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection

right arrow Alfredo Alberti, MD; Franco Noventa, MD; Luisa Benvegnù, MD; Silvia Boccato, MD; and Angelo Gatta, MD

17 December 2002 | Volume 137 Issue 12 | Pages 961-964

Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear.

Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons.

Design: Population-based cross-sectional study.

Setting: Northeastern Italy.

Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors.

Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores).

Results: 116 persons (2.4% [95% CI, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [CI, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (CI, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (CI, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003).

Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.


Editors' Notes
space

Context

  • Many persons infected with hepatitis C virus (HCV) are asymptomatic. The extent of liver disease in these persons is unclear.

Contribution

  • The researchers tested 4820 apparently healthy persons in Italy for hepatitis C virus. Among the 116 (2.4%) who tested positive, 85 were viremic; only about half of these 85 patients had elevated alanine aminotransferase (ALT) levels. Liver biopsy showed substantial inflammation or fibrosis in 19% of persons with normal ALT levels and 61% of persons with abnormal ALT levels.

Implications

  • The substantial prevalence of abnormal liver histology among asymptomatic persons is a provocative but incomplete rationale for screening for HCV. The prevalence of infection and the effectiveness of treatment are also important considerations.

–The Editors

 

Author and Article Information
space

From University of Padova, Padova, Italy.

Grant Support: By a grant from the Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.

Requests for Single Reprints: Alfredo Alberti, MD, Department of Clinical and Experimental Medicine, Clinica Medica 5, University of Padova, Via Giustiniani 2, 35100 Padova, Italy; e-mail, alfredo.alberti{at}unipd.it.

Current Author Addresses: Drs. Alberti, Noventa, Benvegnù, Boccato, and Gatta: Department of Clinical and Experimental Medicine, Clinica Medica 5, Via Giustiniani 2, 35128 Padova, Italy.

Author Contributions: Conception and design: A. Alberti.

Analysis and interpretation of the data: A. Alberti, L. Benvegnù.

Drafting of the article: A. Alberti.

Critical revision of the article for important intellectual content: A. Gatta.

Final approval of the article: A. Alberti, F. Noventa, L. Benvegnù, S. Boccato.

Provision of study materials or patients: S. Boccato.

Statistical expertise: F. Noventa.

Obtaining of funding: A. Alberti.

Collection and assembly of data: A. Alberti, F. Noventa.


Related articles in Annals:

Summaries for Patients
Liver Disease in Persons with Asymptomatic Hepatitis C Virus Infection
Annals 2002 137: I-36. [Full Text]  



This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. Vecchiet, K. Falasca, P. Cacciatore, P. Zingariello, M. Dalessandro, M. Marinopiccoli, E. D'Amico, C. Palazzi, C. Petrarca, P. Conti, et al.
Association between Plasma Interleukin-18 Levels and Liver Injury in Chronic Hepatitis C Virus Infection and Non-Alcoholic Fatty Liver Disease
Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 415 - 422.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M G Rumi, F De Filippi, C La Vecchia, M F Donato, S Gallus, E Del Ninno, and M Colombo
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients
Gut, March 1, 2005; 54(3): 402 - 406.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
A. Tichelli and G. Socie
Considerations for Adult Cancer Survivors
Hematology, January 1, 2005; 2005(1): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. Chou, E. C. Clark, and M. Helfand
Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, March 16, 2004; 140(6): 465 - 479.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Peffault de Latour, V. Levy, T. Asselah, P. Marcellin, C. Scieux, L. Ades, R. Traineau, A. Devergie, P. Ribaud, H. Esperou, et al.
Long-term outcome of hepatitis C infection after bone marrow transplantation
Blood, March 1, 2004; 103(5): 1618 - 1624.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2002 by the American College of Physicians.